MUMBAI, INDIA, August 18, 2026 — Star Struck Times.
In a landmark legal and regulatory crackdown that has sent shockwaves through the Hindi film industry, the Maharashtra Food and Drug Administration (FDA) has officially served show-cause notices to Bollywood mega-stars Shah Rukh Khan, Ajay Devgn, and Tiger Shroff. The regulatory body’s action targets the trio’s prominent participation in high-decibel campaigns for Vimal Elaichi—a promotional drive long alleged by health advocates to be a textbook instance of surrogate advertising for banned gutka and pan masala products.
Adding fuel to an already roaring public debate, veteran actor and cultural commentator Mukesh Khanna broke his silence today, commending the government’s stern notice while demanding nothing short of an explicit, public apology from the A-list stars.
Key Points Summary
- Regulatory Crackdown: The Maharashtra FDA dispatched formal show-cause notices under strict anti-surrogate advertising frameworks to legal entities and personal residences tied to Shah Rukh Khan, Ajay Devgn, and Tiger Shroff.
- 15-Day Deadline: Authorities have given the three superstars a strict 15-day window to justify their association with the “Kesariya Adaab” brand campaign.
- Public Fury & Backlash: Veteran actor Mukesh Khanna publicly blasted the campaign, demanding that the actors apologize to impressionable fans for normalizing toxic product branding under the guise of cardamom.
- Surrogate Advertising Trap: The regulatory body contends that marketing silver-coated cardamom under a brand identity identical to illegal chewable tobacco misleads consumers and violates state public health mandates.
The Big Crackdown: Bollywood’s Billion-Dollar Surrogate Branding Crisis
For years, the phrase “Bolo Zubaan Kesariya” has echoed across television screens, movie theaters, and digital platforms, anchored by some of the most recognizable faces in Indian cinema. However, the glamorous façade surrounding these ultra-lucrative endorsement deals shattered when the Maharashtra FDA took direct enforcement action.
According to official sources, formal notices were delivered directly to Shah Rukh Khan’s Bandra residence Mannat, Ajay Devgn’s Juhu bungalow, and Tiger Shroff’s production outfit. The regulatory notices explicitly question the intent behind promoting Vimal Elaichi—a product sharing the identical brand mark, logo typography, packaging color palette, and tagline of Vimal Pan Masala, a product whose sale and distribution remain prohibited under Maharashtra health statutes.
The FDA’s action asserts that utilizing celebrity equity to bypass anti-tobacco advertising regulations creates a deceptive psychological bridge for impressionable youth, encouraging the indirect consumption of harmful substances.
Mukesh Khanna Fires Back: “Apologize to the Nation”
As news of the legal notices spread across trade circles, veteran actor Mukesh Khanna, renowned for his iconic roles as Shaktimaan and Bhishma Pitamah, issued a scathing public statement. Khanna, who has spent years campaigning against celebrity-backed substance endorsements, did not mince words.
“I am glad the government and the FDA have finally taken note of what I have been shouting from the rooftops for years,” Khanna stated in a video message released to the public. “These huge artists think they are above accountability. They live luxurious lives, yet they use their massive influence to lead the youth down the wrong path with this ‘Kesariya Adaab’ theater.”
Khanna completely dismantled the defense frequently cited by talent management firms—that actors are merely endorsing cardamom.
“They claim they are selling cardamom, but when the brand name, colors, and styling are identical to a banned gutka product, it is deceptive surrogate advertising, plain and simple,” Khanna added. “It is not enough for the government to issue notices. Shah Rukh, Ajay, and Tiger must come forward on public platforms and apologize. They gave the wrong message; now it is their moral duty to fix it.”
+----------------------------------------------------------------------------------------------------+
| CHRONOLOGY OF BOLLYWOOD PAN MASALA AD CONTROVERSIES |
+-------------------+--------------------------------------------------------------------------------+
| YEAR | EVENT / REGULATORY ACTION |
+-------------------+--------------------------------------------------------------------------------+
| October 2021 | Amitabh Bachchan terminates his contract with Kamla Pasand after public outrage|
| | and returns the endorsement fee. |
+-------------------+--------------------------------------------------------------------------------+
| April 2022 | Akshay Kumar faces massive fan backlash for joining the Vimal campaign; issues |
| | a formal public apology and steps back from future contract renewals. |
+-------------------+--------------------------------------------------------------------------------+
| August 2024 | Public advocacy groups and health activists petition consumer protection court |
| | over surrogate ad loopholes utilized by FMCG conglomerates. |
+-------------------+--------------------------------------------------------------------------------+
| August 2026 | Maharashtra FDA issues show-cause notices to Shah Rukh Khan, Ajay Devgn, and |
| | Tiger Shroff; Mukesh Khanna demands a nationwide public apology. |
+-------------------+--------------------------------------------------------------------------------+
What Other Reports Missed: The Financial & Legal Trap for A-Listers
While most outlets focus solely on the celebrity drama, the insider reality reveals a far more complex legal and financial matrix currently playing out behind closed doors in Bandra and Juhu.
- The Contractual Indemnity Clause: Industry insiders reveal that top-tier Bollywood contracts typically feature comprehensive legal indemnity clauses inserted by brand agencies. These clauses state that the brand—not the actor—holds full legal liability for regulatory compliance regarding product classifications. However, under updated consumer protection frameworks, celebrity endorsers are personally liable for due diligence regarding misleading claims.
- The “Surrogate” Loophole Closure: The FDA’s step marks a shift in regulatory enforcement strategy. Previously, authorities targeted distributors and manufacturers. By directing show-cause notices to the personal entities of artists, regulators are establishing a precedent: star power can no longer be used as a shield against public health mandates.
- The Multi-Crore Conundrum: Top-tier actors command anywhere between $1.2\text{ million}$ to $2.5\text{ million}$ ($\approx 10\text{ to } 20\text{ crore INR}$) for multi-year multi-actor campaign deals. Walking away from these contracts involves complex exit negotiations, intellectual property usage disputes, and potential legal countersuits from manufacturing conglomerates.
ENGAGEMENT
- Why did the FDA issue notices to Shah Rukh Khan, Ajay Devgn, and Tiger Shroff?The Maharashtra Food and Drug Administration (FDA) issued show-cause notices to Shah Rukh Khan, Ajay Devgn, and Tiger Shroff because their promotion of Vimal Elaichi allegedly acts as surrogate advertising for Vimal Pan Masala, a prohibited chewable tobacco product in the state.
- What did Mukesh Khanna say about the Vimal advertisement controversy?Mukesh Khanna praised the FDA for taking action against the actors, labeling the campaign deceptive surrogate advertising and demanding that Shah Rukh Khan, Ajay Devgn, and Tiger Shroff issue a public apology for misleading young fans.
Frequently Asked Questions (FAQs)
Q1: What is surrogate advertising in Bollywood endorsements?
Answer: Surrogate advertising occurs when a brand advertises a legal or benign product (like mouth freshener, cardamom, or packaged water) using the exact same brand name, logo, packaging, and slogans as a restricted or banned product (like pan masala, gutka, or alcohol). This maintains high brand recall for the restricted product without directly displaying it.
Q2: Which actors have previously stepped down from pan masala endorsements?
Answer: Amitabh Bachchan canceled his contract with Kamla Pasand in 2021 after learning about public health concerns, and Akshay Kumar publicly apologized to his fans in 2022, promising to step away from his association with Vimal Elaichi upon the expiration of his contract.
Q3: What legal consequences could the actors face if the FDA response is unsatisfactory?
Answer: If the actors fail to provide a legal justification within the 15-day notice period, the FDA can issue directives to ban the broadcast of the ads within the state, initiate proceedings under the Consumer Protection Act for misleading endorsements, and impose financial penalties or broadcast injunctions.
Q4: Is pan masala completely banned in Maharashtra?
Answer: Maharashtra enforces an ban on the manufacture, storage, distribution, and sale of gutka, pan masala, and chewable tobacco products containing nicotine or magnesium carbonate under regulations issued by the Food Safety and Standards Authority of India (FSSAI).
Do you think A-list Bollywood stars should be legally banned from promoting brands associated with pan masala, or is the ultimate responsibility on regulators and consumers? Drop your thoughts in the comments below!
